The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Active Bacterial Core Surveillance of the Emerging Infections Program Network
Open accessAbstract
Active Bacterial Core surveillance (ABCs) is a collaboration between the Centers for Disease Control and Prevention and several state health departments and universities participating in the Emerging Infections Program Network. ABCs conducts population-based active surveillance, collects isolates, and performs studies of invasive disease caused by Streptococcus pneumoniae, group A and group B Streptococcus, Neisseria meningitidis, and Haemophilus influenzae for a population of 17 to 30 million. These pathogens caused an estimated 97,000 invasive cases, resulting in 10,000 deaths in the United States in 1998. Incidence rates of these pathogens are described. During 1998, 25% of invasive pneumococcal infections in ABCs areas were not susceptible to penicillin, and 13.3% were not susceptible to three classes of antibiotics. In 1998, early-onset group B streptococcal disease had declined by 65% over the previous 6 years. More information on ABCs is available at www.cdc.gov/ncidod/dbmd/abcs. ABCs specimens will soon be available to researchers through an archive.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Meningitis in the United States in 1995
Schuchat, A., Robinson, K., Wenger, J. D., Harrison, L. H., Farley, M., Reingold, A. L., Lefkowitz, L., & Perkins, B. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371404 · Cited by 1,251
Self-citationGroup B Streptococcal Disease in the Era of Intrapartum Antibiotic Prophylaxis
Schrag, S. J., Zywicki, S., Farley, M. M., Reingold, A. L., Harrison, L. H., Lefkowitz, L. B., Hadler, J. L., Danila, R., Cieslak, P. R., & Schuchat, A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001063420103 · Cited by 1,024
Self-citation(1997) · PsycEXTRA Dataset · doi:10.1037/e547512006-001 · Cited by 1,000
Pneumococcal resistance to antibiotics
Klugman, K. P. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.2.171 · Cited by 799
Cigarette Smoking and Invasive Pneumococcal Disease
Nuorti, J. P., Butler, J. C., Farley, M. M., Harrison, L. H., McGeer, A., Kolczak, M. S., & Breiman, R. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421002 · Cited by 798
Self-citationEmerging Infections: Microbial Threats to Health in the United States
Lederberg, J., Shope, R. E., & Oaks, S. C. (1992) · Defense Technical Information Center (DTIC) · Cited by 772
Prevention of Perinatal Group B Streptococcal Disease: A Public Health Perspective: (547302006-001)
(1996) · PsycEXTRA Dataset · doi:10.1037/e547302006-001 · Cited by 709
Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era
Adams, W. G. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500020055031 · Cited by 696
Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci
Beall, B., Facklam, R., & Thompson, T. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.4.953-958.1996 · Cited by 601
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.2.223 · Cited by 589
Cited by
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Pilishvili, T., Lexau, C., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Reingold, A., Thomas, A., Schaffner, W., Craig, A. S., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/648593 · Cited by 1,311
Self-citationVaccination greatly reduces disease, disability, death and inequity worldwide
Andre, F., Booy, R., Bock, H., Clemens, J., Datta, S., John, T., Lee, B., Lolekha, S., Peltola, H., Ruff, T., et al. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.040089 · Cited by 1,234
Simonsen, K. A., Anderson-Berry, A. L., Delair, S. F., & Davies, H. D. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-13 · Cited by 984
Bacterial Meningitis in the United States, 1998–2007
Thigpen, M. C., Whitney, C. G., Messonnier, N. E., Zell, E. R., Lynfield, R., Hadler, J. L., Harrison, L. H., Farley, M. M., Reingold, A., Bennett, N. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005384 · Cited by 953
Self-citationEpidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005
Phares, C. R. (2008) · JAMA · doi:10.1001/jama.299.17.2056 · Cited by 878
Global epidemiology of meningococcal disease
Harrison, L. H., Trotter, C. L., & Ramsay, M. E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.063 · Cited by 755
Self-citationLexau, C. A. (2005) · JAMA · doi:10.1001/jama.294.16.2043 · Cited by 671
Roush, S. W. (2007) · JAMA · doi:10.1001/jama.298.18.2155 · Cited by 633
Whitney, C. G., Pilishvili, T., Farley, M. M., Schaffner, W., Craig, A. S., Lynfield, R., Nyquist, A.-C., Gershman, K. A., Vazquez, M., Bennett, N. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69637-2 · Cited by 623
Self-citationSchrag, S. J., Zell, E. R., Lynfield, R., Roome, A., Arnold, K. E., Craig, A. S., Harrison, L. H., Reingold, A., Stefonek, K., Smith, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020205 · Cited by 617
Self-citationPrevention of Perinatal Group B Streptococcal Disease: (548432006-001)
(2002) · PsycEXTRA Dataset · doi:10.1037/e548432006-001 · Cited by 554
Krieger, N., Chen, J. T., Waterman, P. D., Rehkopf, D. H., & Subramanian, S. V. (2005) · American Journal of Public Health · doi:10.2105/ajph.2003.032482 · Cited by 553
Poehling, K. A., Talbot, T. R., Griffin, M. R., Craig, A. S., Whitney, C. G., Zell, E., Lexau, C. A., Thomas, A. R., Harrison, L. H., Reingold, A. L., et al. (2006) · JAMA · doi:10.1001/jama.295.14.1668 · Cited by 463
Self-citationYu, V. L., Chiou, C. C. C., Feldman, C., Ortqvist, A., Rello, J., Morris, A. J., Baddour, L. M., Luna, C. M., Snydman, D. R., Ip, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/377534 · Cited by 451
Increasing Burden of Invasive Group B Streptococcal Disease in Nonpregnant Adults, 1990–2007
Skoff, T. H., Farley, M. M., Petit, S., Craig, A. S., Schaffner, W., Gershman, K., Harrison, L. H., Lynfield, R., Mohle‐Boetani, J., Zansky, S., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/599369 · Cited by 452
Self-citationEvaluation of Universal Antenatal Screening for Group B Streptococcus
Van Dyke, M. K., Phares, C. R., Lynfield, R., Thomas, A. R., Arnold, K. E., Craig, A. S., Mohle-Boetani, J., Gershman, K., Schaffner, W., Petit, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806820 · Cited by 415
Self-citationAsthma as a risk factor for invasive pneumococcal disease
Talbot, T. R., Hartert, T. V., Mitchel, E., Halasa, N. B., Arbogast, P. G., Poehling, K. A., Schaffner, W., Craig, A. S., & Griffin, M. R. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044113 · Cited by 395
Pathogenesis of Staphylococcus aureus Abscesses
Kobayashi, S. D., Malachowa, N., & DeLeo, F. R. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.11.030 · Cited by 351
Pai, R., Moore, M. R., Pilishvili, T., Gertz, R. E., Whitney, C. G., Beall, B., & Active Bacterial Core Surveillance Team (2005) · The Journal of Infectious Diseases · doi:10.1086/498043 · Cited by 330
Group B Streptococcus ( Streptococcus agalactiae )
Raabe, V. N., & Shane, A. L. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0007-2018 · Cited by 330
Bloomfield, S. F., Aiello, A. E., Cookson, B., O'Boyle, C., & Larson, E. L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.07.001 · Cited by 328
Population-Based Epidemiology and Microbiology of Community-Onset Bloodstream Infections
Laupland, K. B., & Church, D. L. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-14 · Cited by 323
Isaacman, D. J., McIntosh, E. D., & Reinert, R. R. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.05.010 · Cited by 321
Community-acquired bacterial meningitis
van de Beek, D., Brouwer, M., Hasbun, R., Koedel, U., Whitney, C. G., & Wijdicks, E. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.74 · Cited by 312
Tazi, A., Disson, O., Bellais, S., Bouaboud, A., Dmytruk, N., Dramsi, S., Mistou, M.-Y., Khun, H., Mechler, C., Tardieux, I., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092594 · Cited by 310
Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers
McNeil, S. A., Halperin, S. A., Langley, J. M., Smith, B., Warren, A., Sharratt, G. P., Baxendale, D. M., Reddish, M. A., Hu, M. C., Stroop, S. D., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/444458 · Cited by 305
Healthcare utilization and cost of pneumococcal disease in the United States
Huang, S. S., Johnson, K. M., Ray, G. T., Wroe, P., Lieu, T. A., Moore, M. R., Zell, E. R., Linder, J. A., Grijalva, C. G., Metlay, J. P., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.02.088 · Cited by 296
Self-citationZhanel, G. G., DeCorby, M., Laing, N., Weshnoweski, B., Vashisht, R., Tailor, F., Nichol, K. A., Wierzbowski, A., Baudry, P. J., Karlowsky, J. A., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01538-07 · Cited by 271
Principles of Judicious Antibiotic Prescribing for Upper Respiratory Tract Infections in Pediatrics
Hersh, A. L., Jackson, M. A., Hicks, L. A., the COMMITTEE ON INFECTIOUS DISEASES, Brady, M. T., Byington, C. L., Davies, H. D., Edwards, K. M., Maldonado, Y. A., Murray, D. L., et al. (2013) · Pediatrics · doi:10.1542/peds.2013-3260 · Cited by 266
Economic Evaluation of the Routine Childhood Immunization Program in the United States, 2009
Zhou, F., Shefer, A., Wenger, J., Messonnier, M., Wang, L. Y., Lopez, A., Moore, M., Murphy, T. V., Cortese, M., & Rodewald, L. (2014) · Pediatrics · doi:10.1542/peds.2013-0698 · Cited by 259
Simonsen, L., Taylor, R. J., Young-Xu, Y., Haber, M., May, L., & Klugman, K. P. (2011) · mBio · doi:10.1128/mbio.00309-10 · Cited by 256
Genome-wide antisense transcription drives mRNA processing in bacteria
Lasa, I., Toledo-Arana, A., Dobin, A., Villanueva, M., de los Mozos, I. R., Vergara-Irigaray, M., Segura, V., Fagegaltier, D., Penadés, J. R., Valle, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113521108 · Cited by 254
Halasa, N. B., Shankar, S. M., Talbot, T. R., Arbogast, P. G., Mitchel, E. F., Wang, W. C., Schaffner, W., Craig, A. S., & Griffin, M. R. (2007) · Clinical Infectious Diseases · doi:10.1086/516781 · Cited by 253
Serious Infections Caused by Methicillin‐Resistant Staphylococcus aureus
Boucher, H., Miller, L. G., & Razonable, R. R. (2010) · Clinical Infectious Diseases · doi:10.1086/653519 · Cited by 252
Henneke, P., Takeuchi, O., Malley, R., Lien, E., Ingalls, R. R., Freeman, M. W., Mayadas, T., Nizet, V., Akira, S., Kasper, D. L., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3970 · Cited by 145
Zhou, H., & Kobzik, L. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0293oc · Cited by 129
Aetiologies and risk factors for neonatal sepsis and pneumonia mortality among Alaskan infants
GESSNER, B. D., CASTRODALE, L., & SORIANO-GABARRO, M. (2005) · Epidemiology and Infection · doi:10.1017/s0950268805004449 · Cited by 16
Metadata
- Authors
- Schuchat, A., Hilger, T., Zell, E., Farley, M. M., Reingold, A., Harrison, L., Lefkowitz, L., Danila, R., Stefonek, K., Barrett, N., Morse, D., Pinner, R., & for the Active Bacterial Core Surveillance Team of the Emerging Infections Program Network
- Venue
- Emerging Infectious Diseases
- Published
- 2001-01
- Volume
- 7
- Issue
- 1
- Pages
- 92-99
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2144235181
- Cited by
- 592
- References
- 31
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.